PIQ — Proteomics International Laboratories Share News
0.000.00%
Last trade - 00:00- AU$19.82m
- AU$16.40m
- AU$3.37m
Brief: Proteomics International Laboratories Extends Distribution Agreement For Promarkerd In Britain
Proteomics climbs on nod from American Medical Association
Brief: Proteomics International Laboratories Says FY Loss Attributable A$5.0 Mln
Australia's Proteomics hits near two-week low on discounted placement
Brief: Proteomics International Laboratories Gets Firm Commitments To Raise A$8 Mln
Brief: Proteomics International Laboratories Seeks Trading Halt
Australia's Proteomics climbs on exclusive U.S. product licence
Brief: Proteomics International Laboratories Signs Exclusive LOI With Sonic Healthcare U.S.
Brief: Proteomics International Laboratories Seeks Trading Halt
Australia's Proteomics rises on developing potential blood test to detect endometriosis
Brief: Proteomics International Laboratories Secures Exclusive Licence To Commercialise Oesophageal Cancer Biomarkers
Australia's Proteomics International climbs on biomarker commercialisation deal
Australia Stock Exchange release from PROTEOMICS INTER : PromarkerD patent granted in India
Australia Stock Exchange release from PROTEOMICS INTER : Investor Presentation
Australia Stock Exchange release from PROTEOMICS INTER : Appendix 4D and Interim Financial Report
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 12:33:20
Australia Stock Exchange release from PROTEOMICS INTER : PromarkerD completes 'pre-assessment' for Medicare rebate
Australia Stock Exchange release from PROTEOMICS INTER : PRE_NR Ends: 08:31:25
Australia Stock Exchange release from PROTEOMICS INTER : Exercise of Options